XCounter Trading Update (4607O)

TIDMXCT

RNS Number : 4607O

XCounter AB

19 September 2011

PRESS RELEASE

Stockholm, 19 September 2011

Trading Update

XCounter AB (AIM: XCT) ("XCounter" or the "Company"), a technology leader in the development of photon counting X-ray detectors and tomosynthesis based 3D medical imaging, announces a trading update for the 6 months to 30 June 2011 in advance of its Interim Results which are scheduled to be announced at the end of September 2011.

-- Net sales rose 61.3% to SEK 25.9m (GBP2.5m) (H1 2010: SEK 16.3m (GBP1.6m))

-- Group loss before tax reduced 55.7% to SEK 8.1m (GBP0.8m) (H1 2010: SEK 18.2m (GBP1.8m))

-- Group loss reduced 51.2% to SEK 8.4m (GBP0.8m) (H1 2010: SEK 17.3m (GBP1.7m))

-- Current confirmed customer orders for deliveries before end 2011 represent SEK 25.7 million (GBP2.5m), an increase of 85.2% on the comparable prior year figure

-- On 29 June 2011, XCounter announced an exclusive, worldwide agreement for the development and supply of photon counting digital X-ray detector technologies with a leading healthcare imaging company. Depending on the success of the project, the deal has an aggregate value of up to EUR50m over the next nine years

The financial statements are being prepared under the assumption of going concern.

Mikael Strindlund, CEO of XCounter, commented, "Our first 6 months 2011 show a significant business development which is fully in line with our defined strategy and overall targets."

For further information, please contact:

XCounter AB Tel: [phone]

Mikael Strindlund, CEO

Nomura Code Securities Tel: [phone]

Phil Walker

Capital MS&L Tel: [phone]

Anna Davies

About XCounter AB XCounter AB is a leader in the development of photon counting detector and tomosynthesisbased 3D medical imaging technology. For more information, please visit: www.xcounter.se.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TSTLIFVEARIALIL